Sign Up
Stories
60 Degrees Pharmaceuticals Raises $2.4M
Share
Antivenom Market Booms: Future Projectio...
Experts Warn Against Using Disinfectants...
Recce Pharmaceuticals Advances in Pharma...
ANJESO Drug Insight and Market Forecast
Overview
API
60 Degrees Pharmaceuticals, Inc. closes a public offering raising $2.4 million for working capital, FDA-approved product relaunch, and research & development.
Ask a question
How does the subsidiary in Australia contribute to the company's overall strategy and market presence?
How might the funding impact the company's operations and future product development?
What potential challenges could arise in relaunching the FDA-approved product for malaria prevention?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Jan 2024
Coverage